Different spinal morphine doses for pain relief after hip replacement
Official title: Comparison of Safety Profile and Efficacy of Different Doses of Intrathecal Morphine in Total Hip Replacement.
Run by Medical University of Silesia · NCT06878014 · Data updated 2026-11-12
This trial tests whether different doses of morphine given with spinal anesthesia reduce pain and balance safety after total hip replacement in adults.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Medical University of Silesia Academic / other |
| Locations | 3 sites (Sosnowiec, Silesian Voivodeship and 2 other locations) |
| Status | Recruiting |
| Started | March 4, 2025 |
| Main results expected | June 28, 2026 |
| Study ends | June 28, 2026 |
| Registry record updated | February 12, 2026 |
| Trial ID | NCT06878014 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults scheduled for elective total hip replacement who are ASA physical status I–III, have BMI 19–30, can operate a PCA pump, and can give informed consent are ideal candidates.
✕Probably not a fit
Patients with BMI over 30, chronic preoperative pain or regular opioid use, contraindications to spinal anesthesia, or inability to use a PCA pump may not receive benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults having elective total hip replacement receive spinal bupivacaine combined with varying doses of intrathecal morphine and standardized postoperative multimodal analgesia, including acetaminophen, an NSAID or metamizole, and PCA IV oxycodone as needed. The study tracks pain scores, opioid consumption, and adverse events—with particular attention to respiratory depression—primarily during the first 24 hours after surgery. Eligible participants are ASA I–III with BMI 19–30, able to use a PCA pump, and without chronic preoperative opioid use or contraindications to spinal anesthesia. The goal is to find a morphine dose that prolongs pain relief while minimizing serious side effects.
Why it matters
Potential benefit: If successful, the trial could identify a morphine dose that provides longer post-operative pain relief with fewer serious side effects like respiratory depression.
How similar studies have gone: Prior research shows intrathecal morphine prolongs postoperative analgesia but carries dose-dependent risk of respiratory depression, so dose-finding work is common and needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed consent to participate in trial * Qualification for total hip replacement surgery * ASA physical status I-III * BMI 19-30 * Lack of contraindications for drugs and interventions used in trial Exclusion Criteria: * Incapability to provide informed consent * Contraindications for spinal anesthesia * Preoperative chronic pain * Chronic use of analgesics * Obesity (BMI\>30) * Allergies and other contraindications for drugs used in trial * Mental or physical incapability to operate PCA syringe pump
Where it's running
-
Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary
Sosnowiec, Silesian Voivodeship, Poland Recruiting -
Zespół Opieki Zdrowotnej w Końskich
Gmina Końskie, Świętokrzyskie Voivodeship, Poland Recruiting -
Uniwersytecki Szpital Kliniczny nr 1 im. prof. Tadeusza Sokołowskiego PUM w Szczecinie
Szczecin, West Pomeranian Voivodeship, Poland Not yet recruiting
Study contacts
- Study coordinator: Szymon Białka, MD PhD
- Email: szymon.bialka@gmail.com
- Phone: +48323407593
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perfusion Index as a Predictor of Spinal Anesthesia–Induced Hypotension in Day-Case Knee Arthroscopy
This study looks to see if a baseline perfusion index can predict low blood pressure after spinal anesthesia in healthy adults having knee arthroscopy.
-
Quality of Recovery after opioid-free vs opioid-based general anesthesia in major urological surgery
This trial tests whether opioid-free anesthesia leads to a better recovery score, as measured by QoR-15, in adults undergoing major urological surgery compared to anesthesia with remifentanil.
-
Dressing experiences and self-care after hip or knee replacement
This observational study tests how patients manage dressings and wound care after hip or knee replacement within an ERAS pathway, to see how comfortable the dressings are and what education patients find helpful.
-
Binaural beats to reduce pain and anxiety after hip or knee replacement
This will try a 30-minute binaural beats audio session in the PACU to see if it lowers pain and anxiety for adults having same-day total hip or knee replacement.
-
Suzetrigine for pain control after primary total hip replacement
This will test whether taking Suzetrigine before surgery and for seven days afterward reduces opioid use and improves pain control in adults having a primary total hip replacement.
-
Intrathecal morphine and urinary retention after revision knee replacement
This study will see if adding a small dose of spinal (intrathecal) morphine for adults having revision knee replacement lowers early pain but raises the chance of needing a urinary catheter.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.